UBS AG
Screenreader-optimized Version for visually impaired and blind visitors Home | Accessibility | Zoom version | Local Sitemap | Service Finder | eng deu fra ita | Search
   
Annual Reporting 2006  
Annual Review Financial Report Handbook
     
Introduction
UBS
Our employees
Our Businesses
Industrial Holdings
Risk management
Treasury management
Capital management & UBS shares
Corporate Governance
Corporate Responsibility
 

Market risk
Market risk

Regulatory capital treatment of market risk
Regulatory capital treatment of market risk

Our VaR model is consistent with the regulatory measure of market risk capital and has been approved by the Swiss Federal Banking Commission (SFBC), our main regulator.

The majority of our trading activities fall under the definition of "trading book" for regulatory capital treatment. This means that both general and idiosyncratic market risks in these books are subject to a market risk capital requirement. It also means that the securities and other exposures to single names in tradable form are not generally subject to "banking book" capital requirements, which are typically higher. If a trading position in such an asset ceases to be eligible for trading book treatment (for example if it becomes illiquid), it must be underpinned by capital on a banking book basis, but it remains subject to the market risk control framework for internal control purposes.

In first quarter 2006, the SFBC approved the inclusion of our base metals and soft commodities derivatives trading business in VaR for regulatory capital purposes. It was included in both our external disclosure and our market risk regulatory capital from 15 March 2006, but its incremental impact was minimal.

All non-trading foreign exchange exposures (other than structural positions – see "Treasury Management" chapter) are included in VaR for regulatory capital purposes. There are some non-material legacy commodities positions in the form of warrants for which the market risk capital requirement is calculated using the "standardized method" prescribed by regulation. Other non-trading general market risks (interest rate and equity) are not subject to a market risk capital charge but interest rate risk which is not included in VaR for regulatory capital purposes is reported to Swiss regulators.

Further explanation of regulatory capital treatment is provided in note 29 of our Financial Report 2006.

Terms of Use | Privacy Statement

Products and services in these webpages may not be available for residents of certain nations. Please consult the sales restrictions relating to the service in question for further information.

© UBS 1998-2009. All rights reserved.

 
Create your own report 
Create your own report

Create your own report by searching and selecting articles of our Annual Reporting products.

Search only in
Annual Reporting 2006 
Search